Ugurluoglu A, Katzenschlager R, Ahmadi R, Atteneder M, Koppensteiner R, Lang G, Maca T, Minar E, Schneider B, Stümpflen A, Ehringer H
Department of Medical Angiology, University of Vienna.
Vasa. 1997 May;26(2):110-6.
The following study was designed to evaluate the effectiveness and safety of ultrasound guided compression therapy (UGCT) of iatrogenic postcatheterization pseudo-aneurysms (PA) on the one hand and to justify the usefulness of the routine colour duplex control of the puncture site following transfemoral catheterization, on the other hand.
During the study period 142 patients with (PA) following transfemoral catheterization were identified by means of colour duplex examination Eighty of these 142 patients were identified during a routine colour duplex control of the puncture site the day after PTA/angiography because of peripheral arterial occlusive disease (PAOD) [group A]; the remaining 62 patients with symptomatic groins were referred from other departments [group B].
In 8 patients of group B UGCT was considered to be contra-indicated, they were primarily treated by surgical repair of the PA. A total of 134 patients (group A 80 patients, group B 54 patients) underwent an UGCT. In total the success rate of UGCT was in group A 100% and in group B 78%. 12/54 patients (all group B) with failure of UGCT underwent a secondary surgical repair of the PA. Within group B there was a negative correlation between delay of diagnosis/UGCT and success (p < 0.04), whereas the size of the sheath did not influence the outcome of the UGCT (p = 0.3).
Our study confirms the effectiveness and safety of UGCT. Routine colour duplex control of the puncture site the day following the removal of the sheath after percutaneous catheterization and UGCT of PAs without delay can increase the success rate of UGCT and minimize the need for surgical repair of PAs.
以下研究旨在一方面评估超声引导下压迫疗法（UGCT）治疗医源性导管插入术后假性动脉瘤（PA）的有效性和安全性，另一方面验证经股动脉导管插入术后穿刺部位常规彩色双功超声检查的实用性。
在研究期间，通过彩色双功超声检查确定了142例经股动脉导管插入术后患有PA的患者。这142例患者中，80例是在因外周动脉闭塞性疾病（PAOD）进行PTA/血管造影术后第二天对穿刺部位进行常规彩色双功超声检查时发现的[组A]；其余62例有腹股沟症状的患者是从其他科室转诊而来的[组B]。
组B中有8例患者被认为UGCT治疗禁忌，他们主要接受了PA的外科修复。共有134例患者（组A 80例，组B 54例）接受了UGCT。总体而言，UGCT的成功率在组A中为100%，在组B中为78%。12/54例UGCT治疗失败的患者（均为组B）接受了PA的二次外科修复。在组B中，诊断/UGCT延迟与成功率之间呈负相关（p < 0.04），而鞘管大小并未影响UGCT的治疗结果（p = 0.3）。
我们的研究证实了UGCT的有效性和安全性。经皮导管插入术后拔除鞘管次日对穿刺部位进行常规彩色双功超声检查，并及时对PA进行UGCT治疗，可提高UGCT的成功率，并最大限度减少PA外科修复的需求。
